Literature DB >> 7684296

Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP.

A Ben-Jebria1, R Marthan, M Rossetti, J P Savineau.   

Abstract

1. The effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by the following neuropeptides substance P (SP), neurokinin A (NKA) and vasoactive intestinal peptide (VIP) was studied both in the absence and in the presence of the neutral endopeptidase (NEP) inhibitor, phosphoramidon. 2. Cumulative concentration-response curves (CCRC) to these neuropeptides were constructed in human passively sensitized isolated bronchial rings and compared to those in paired controls. Passively sensitized human isolated bronchial rings were tissues incubated overnight in serum from asthmatic patients atopic to Dermatophagoides pteronyssinus and paired controls were tissues originating from the same lung specimens but incubated overnight in serum from healthy donors. 3. In the absence of phosphoramidon, passive sensitization significantly increased the amplitude of the contractile responses to SP and NKA including that to the maximal concentration given from 50 +/- 5% to 76 +/- 6% (n = 5, P < 0.05) and from 70 +/- 7% to 101 +/- 6% (n = 5, P < 0.05) of the maximal response to acetylcholine, respectively. Passive sensitization significantly shifted to the left the CCRC for both tachykinins as measured by the geometric means dose-ratios which were 8.5 (95% confidence limits (CL): 3.1-13.9) and 7.3 (95% CL: 4.2-10.3) for SP and NKA, respectively. 4. In the presence of phosphoramidon (10 microM), passive sensitization still increased significantly the amplitude of the contractile responses to SP and NKA including that to the maximal concentration given from 74 +/- 4% to 115 +/- 7% (n = 5, P<0.05) and from 104 +/- 9% to 146 +/- 16% (n = 5, P<0.05)of the maximal response to acetylcholine, respectively. Passive sensitization still significantly shifted to the left the CCRC for both tachykinins as measured by the dose-ratios which were 9.0 (95% CL:4.3-13.6) and 5.4 (95% CL: 2.9-7.9) for SP and NKA, respectively.5. The relaxant response to the maximal concentration of VIP given in tissues precontracted with histamine (0.5 mM) was significantly reduced by passive sensitization from 41 +/- 4% to 25 +/- 3% (n = 5,P <0.05) of the amplitude of the precontraction in the absence of phosphoramidon and from 72 +/- 1%to 49 +/- 4% (n = 5, P<0.05) in the presence of phosphoramidon (10 microM). Passive sensitization significantly shifted to the right the CCRC for VIP as measured by the dose-ratios which were 10.4(95% CL: 6.6-14.1) and 6.4 (95% CL: 3.0-9.8) in the absence and in the presence of phosphoramidon,respectively.6. We conclude that passive sensitization enhances the mechanical response to neuropeptides which contract human isolated bronchial smooth muscle and reduces that to a neuropeptide which relaxes it.The mechanism of passive sensitization-induced changes in the mechanical activity appears to be independent of a decrease in NEP activity since these changes persist in the presence of the NEP inhibitor, phosphoramidon.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684296      PMCID: PMC2175608          DOI: 10.1111/j.1476-5381.1993.tb13542.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Differential effects of phosphoramidon on neurokinin A- and substance P-induced airflow obstruction and airway microvascular leakage in guinea-pig.

Authors:  J O Lötvall; W Elwood; K Tokuyama; P J Barnes; K F Chung
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Sensory neuropeptides and airway function.

Authors:  J Solway; A R Leff
Journal:  J Appl Physiol (1985)       Date:  1991-12

3.  Potentiation of the contractile effects of neuropeptides in human bronchus by an enkephalinase inhibitor.

Authors:  J L Black; P R Johnson; C L Armour
Journal:  Pulm Pharmacol       Date:  1988

4.  The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.

Authors:  P J Barnes; C M Dixon
Journal:  Am Rev Respir Dis       Date:  1984-08

5.  In vivo bronchodilator activity of vasoactive intestinal peptide in the cat.

Authors:  L Diamond; J L Szarek; M N Gillespie; R J Altiere
Journal:  Am Rev Respir Dis       Date:  1983-11

6.  Nonadrenergic inhibitory nervous system in human airways.

Authors:  J Richardson; J Béland
Journal:  J Appl Physiol       Date:  1976-11       Impact factor: 3.531

7.  Receptor mechanisms for 5-hydroxytryptamine in rabbit arteries.

Authors:  J L Black; R J French; E J Mylecharane
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

8.  Responsiveness to histamine in human sensitized airway smooth muscle.

Authors:  R Marthan; H Crevel; H Guénard; J P Savineau
Journal:  Respir Physiol       Date:  1992-11

9.  Reflex decrease of histamine-induced bronchoconstriction after laryngeal stimulation in asthmatic patients.

Authors:  M C Michoud; A Jeanneret-Grosjean; A Cohen; R Amyot
Journal:  Am Rev Respir Dis       Date:  1988-12

10.  The action of sodium cromoglycate on 'C' fibre endings in the dog lung.

Authors:  M Dixon; D M Jackson; I M Richards
Journal:  Br J Pharmacol       Date:  1980-09       Impact factor: 8.739

View more
  6 in total

1.  Contractile responses to adenosine, R-PIA and ovalbumen in passively sensitized guinea-pig isolated airways.

Authors:  Timothy J Martin; Kenneth J Broadley
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects.

Authors:  L G Heaney; L J Cross; L P McGarvey; K D Buchanan; M Ennis; C Shaw
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

3.  Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro.

Authors:  J J Maguire; R E Kuc; G O'Reilly; A P Davenport
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

4.  Activation properties of chemically skinned fibres from human isolated bronchial smooth muscle.

Authors:  J P Savineau; R Marthan
Journal:  J Physiol       Date:  1994-02-01       Impact factor: 5.182

5.  Expression and function of human hemokinin-1 in human and guinea pig airways.

Authors:  Stanislas Grassin-Delyle; Emmanuel Naline; Amparo Buenestado; Paul-André Risse; Edouard Sage; Charles Advenier; Philippe Devillier
Journal:  Respir Res       Date:  2010-10-07

6.  The pivotal role of airway smooth muscle in asthma pathophysiology.

Authors:  Annaïg Ozier; Benoit Allard; Imane Bara; Pierre-Olivier Girodet; Thomas Trian; Roger Marthan; Patrick Berger
Journal:  J Allergy (Cairo)       Date:  2011-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.